1Casey DE,Zorn SH.The pharmacology of weight gain with antipsychotics[J].J Clin Psychiatry,2001,62(Suppl 7):5-7. 被引量：1
2Lieberman JA,Tollefson G,Tohen M,et al.Comparative efficacy and saftey of atipical and conventional antipsychotic drugs in first-episode psychosis:A randomized,double-blind trial of olanzapine versus haloperidol[J].Am J Psychiatry,2003,160:1401-1403. 被引量：1
3Zhang ZJ,Yao ZJ,Liu W.Effects of antipsychotics on fat deposition and changes in leptin and insulin levels[J].Br J Psychiatry,2004,184:58. 被引量：1
4Buse JB.Metabolic side effects of astipsychtics:focus on hyperglycemia and diabetes[J].J Clin Psychiatry,2002,63(Suppl 4):37-41. 被引量：1
5Sernyak MJ,Leslie DL,Alarcon RD,et al.Association of diabetes mellitus with use of atypical neuroleptic in the treatment of schizophrenia[J].Am J Psychiatry,2002,159:561-566. 被引量：1
6Hgg S,joelsson L,Mjndal T,et al.Prevalence of diabetes and impaired glucose tolerance in patients with conventional depot neuroleptic medications[J].J Clin Psychiatry,1998,59:294-295. 被引量：1
7Mir S,Taylor D.Atypical antipsychotics and hyperglycaemia[J].Int Clin Psychopharmacol,2001,16:63-73. 被引量：1
8Jin H,Meyer JM,Jeste DV.Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associaated with atypical antipsychotic:an analysis of 45 published cases[J].Ann Clin Pschiatry,2002,14:59-64. 被引量：1
